NovoCure annual meeting: directors re-elected, compensation advisory passes with 33% dissent

1. Election of Directors . The ten nominees for election to the Company’s Board of Directors were elected as directors to hold office until the Company’s 2024 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes: For Against Abstain Broker non-votes Asaf Danziger 77,038,664 438,380 37,244 11,181,863 William Doyle 75,140,162 2,337,997 36,129 11,181,863 Jeryl Hilleman 76,517,018 961,608 35,662 11,181,863 David Hung 76,570,935 905,818 37,535 11,181,863 Kinyip Gabriel Leung 75,970,544 1,506.589 37,155 11,181,863 Martin Madden 76,681,847 800,747 31,694 11,181,863 Allyson Ocean 77,217,389 267,279 29,620 11,181,863 Timothy Scannell 74,042,103 3,439,901 32,284 11,181,863 Kristin Stafford 77,300,405 180,458 33,425 11,181,863 William Vernon 75,337,605 2,144,734 31,949 11,181,863

3. Approval of a non-binding advisory vote to approve executive compensation . The proposal to approve executive compensation on a non-binding advisory basis was approved as an ordinary resolution based upon the following votes: For Against Abstain Broker non-votes 52,182,720 25,266,346 65,222 11,181,863

2. Ratification of Independent Registered Public Accounting Firm . The proposal to approve and ratify the appointment, by the Audit Committee of the Company’s Board of Directors, of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the auditor and independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023 was approved as an ordinary resolution based upon the following votes: For Against Abstain 87,443,163 1,174,411 78,577